Hickerson Quoted on Global Sensitivity Regarding Genetically Modified Crops
12 September 2014
Partner David Hickerson was quoted in a Wall Street Journal piece, “Cargill Sues Syngenta Over Sale of GMO Seeds Unapproved in China,” on September 12, 2014, discussing the global issues surrounding genetically modified crops. Hickerson noted that Syngenta faced no contractual obligations with Cargill and was quoted saying, “A real issue will be: What duty did Syngenta owe to Cargill? Syngenta may argue, ‘We are just legally selling our product. If you wanted to sell that product to China, it was your obligation to make sure it complied with whatever import rules applied.’”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”